ACE2, the COVID-19 receptor, was included in COVID-19 cocktails since plasma sACE2 levels are significantly higher in COVID-19 patients in intensive care (34, 35) and in elderly and metabolic syndrome patients who are predisposed to severe COVID-19 disease (36). This evidence concerns the gene ACE2 and metabolic syndrome.